Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina

NCT03789552 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
765
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tasly Pharmaceuticals, Inc.